首页> 外文期刊>American Journal of Physiology >The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors
【24h】

The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors

机译:抗哮喘草药ASHMI通过前列腺素E2激活EP2 / EP4受体急性抑制气道平滑肌收缩

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Our previous studies have shown that the anti-asthma traditional Chinese medicine herbal formula ASHMI (anti-asthma simplified herbal medicine intervention) inhibits acetylcholine-induced contractions of tracheal rings from ovalbumin-sensitized and naive mice in a (β-adreno-ceptor-independent manner. We sought to determine whether acute in vivo ASHMI administration inhibits airway hyperreactivity (AHR) in a murine model of allergic asthma and acetylcholine-induced tracheal ring constriction ex vivo and to elucidate the cellular mechanisms underlying these effects. Ovalbumin-sensitized mice received a single oral ASHMI dose 2 h before intravenous acetylcholine challenge. AHR was determined by invasive airway measurements. Myography was used to determine the effects of ASHMI on acetylcholine-induced constriction of tracheal rings from asthmatic mice with or without epithelial denudation. The effect of cyclooxygenase inhibition and EP2/EP4 receptor blockade on ASHMI attenuation of acetylcholine contractions was evaluated. Tracheal cAMP and PGE2 levels were measured by ELISA. A single acute oral dose of ASHMI dramatically reduced AHR in response to acetylcholine provocation in ovalbumin-sensitized mice (P 0.001). In ex vivo experiments, ASHMI significantly and dose-dependently reduced tracheal ring constriction to acetylcholine (P 0.05-0.001), which was epithelium independent and associated with elevated cAMP levels. This effect was abrogated by cyclooxygenase inhibition or EP2/EP4 receptor blockade. ASHMI also inhibited contraction to high K+ (P 0.001). ASHMI increased tracheal ring PGE2 release in response to acetylcholine or high K+ (P 0.05 for both). ASHMI produced direct and acute inhibition of AHR in vivo and blocked acetylcholine-induced tracheal ring constriction via the EP2/EP4 receptor pathway, identifying the mechanism by which ASHMI is an orally active bronchoprotective agent.
机译:我们以前的研究表明,抗哮喘中草药配方ASHMI(抗哮喘简化草药干预)可抑制乙酰胆碱诱导的卵清蛋白敏感和幼稚小鼠的气管环收缩(独立于β-肾上腺素受体)我们试图确定在急性变应性哮喘和乙酰胆碱诱导的气管环收缩的小鼠模型中,急性体内ASHMI给药是否抑制气道高反应性(AHR),并阐明这些作用的细胞机制。静脉内乙酰胆碱激发前2小时单次口服ASHMI剂量;通过有创气道测量确定AHR;通过肌电图确定ASHMI对乙酰胆碱诱发的哮喘小鼠气管环收缩的作用(有或没有上皮剥脱);环氧合酶抑制作用和EP2 / EP4受体阻滞剂对乙酰胆碱的ASHMI减弱评估胆碱收缩。通过ELISA测量气管cAMP和PGE2水平。在卵白蛋白敏感的小鼠中,单次急性口服ASHMI可以显着降低乙酰胆碱激发引起的AHR(P <0.001)。在离体实验中,ASHMI显着且剂量依赖性地降低了气管环收缩至乙酰胆碱的浓度(P <0.05-0.001),这与上皮无关,并与cAMP水平升高有关。环氧合酶抑制或EP2 / EP4受体阻滞消除了该作用。 ASHMI还抑制收缩至高K +(P <0.001)。 ASHMI增加了对乙酰胆碱或高K +的响应,气管环PGE2的释放(两者P均<0.05)。 ASHMI在体内产生了对AHR的直接和急性抑制作用,并通过EP2 / EP4受体途径阻断了乙酰胆碱诱导的气管环收缩,从而确定了ASHMI是口服活性支气管保护剂的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号